Is FPH or CCS a better buy right now?

Based on our latest analysis, CCS is currently the stronger investment candidate based on our comprehensive scoring model.

Does FPH or CCS have better growth?

Our analysis compares revenue and earnings growth. Check the 'Growth' section above to see which company is expanding faster. Typically, the stock with higher revenue growth rates is considered the better growth stock.

Which stock is cheaper: FPH or CCS?

We compare P/E ratios and other valuation metrics in the 'Valuation' section. The stock with the lower P/E ratio is generally considered 'cheaper' relative to its earnings, though growth prospects must also be considered.

Which is the better buy right now, FPH or CCS?

As of Oct 21, 2026, CCS scores higher in our model: FPH has an AI score of 46.5 versus 62.2 for CCS. FPH is currently in a Markdown technical phase and CCS is in a Markdown phase. Consider both scores and phases alongside your own risk tolerance.

What technical phase are FPH and CCS in?

FPH is in a Markdown phase (Sell / avoid) with an RSI of 37.6. CCS is in a Markdown phase (Sell / avoid) with an RSI of 36.8.

FPH vs CCS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

FPH

46.5

AI Score

CCS Wins

CCS

62.2

AI Score

Investment Advisor Scores

FPH

47score

Recommendation

HOLD

View Full Analysis

CCS

62score

Recommendation

BUY

View Full Analysis

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric	FPH	CCS	Winner
Revenue	27.48M	1.72B	CCS
Net Income	8.63M	60.56M	CCS
Net Margin	31.4%	3.5%	FPH
ROE	0.4%	2.4%	CCS
ROA	0.3%	1.3%	CCS
Total Assets	3.22B	4.69B	CCS
Cash	348.38M	92.33M	FPH
Free Cash Flow	-54.83M	-146.69M	FPH

Relative Price Performance (Last 90 Days)

FPH 1M: -12.6% · 3M: -14.2% CCS 1M: -15.0% · 3M: -21.6%

Current Technical Phase

FPH

Markdown

Sell / avoid

Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 38

RSI (14): 37.6 · Price: $4.30

CCS

Markdown

Sell / avoid

Price below a falling SMA50 (slope -6.5%), weak momentum, RSI 37

RSI (14): 36.8 · Price: $54.28

Fundamentals Snapshot

Metric	FPH	CCS
Market Cap	—	—
Forward P/E	11.3	11.8
Trailing P/E	6.3	12.2
Revenue (TTM)	—	—
Revenue Growth	0.9%	-0.1%
Gross Margin	0.5%	0.2%
Operating Margin	-0.5%	0.1%
EPS	0.71	4.55
Dividend Yield	—	0.02%

Frequently Asked Questions

Based on our detailed analysis, CCS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.

Related Analysis

FPH

CCS

Data derived from SEC EDGAR filings and Tradestie proprietary analysis. Last updated: Oct 21, 2026 20:49 UTC. Refresh Data

Tradestie